Pharmacokinetic pharmacogenetic prescribing guidelines for antidepressants: a template for psychiatric precision medicine
M Nassan, WT Nicholson, MA Elliott, CRR Vitek… - Mayo Clinic …, 2016 - Elsevier
Antidepressants are commonly prescribed medications in the United States, and there is
increasing interest in individualizing treatment selection for more than 20 US Food and Drug …
increasing interest in individualizing treatment selection for more than 20 US Food and Drug …
Development of human membrane transporters: drug disposition and pharmacogenetics
MG Mooij, AT Nies, CAJ Knibbe, E Schaeffeler… - Clinical …, 2016 - Springer
Membrane transporters play an essential role in the transport of endogenous and
exogenous compounds, and consequently they mediate the uptake, distribution, and …
exogenous compounds, and consequently they mediate the uptake, distribution, and …
Characterization of the microDNA through the response to chemotherapeutics in lymphoblastoid cell lines
P Mehanna, V Gagné, M Lajoie, JF Spinella… - PloS one, 2017 - journals.plos.org
Recently, a new class of extrachromosomal circular DNA, called microDNA, was identified.
They are on average 100 to 400 bp long and are derived from unique non-repetitive …
They are on average 100 to 400 bp long and are derived from unique non-repetitive …
Pharmacogenomic markers of methotrexate response in the consolidation phase of pediatric acute lymphoblastic leukemia treatment
Methotrexate (MTX) is one of the staples of pediatric acute lymphoblastic leukemia (ALL)
treatment. MTX targets the folate metabolic pathway (FMP). Abnormal function of the …
treatment. MTX targets the folate metabolic pathway (FMP). Abnormal function of the …
Association of microRNA polymorphisms with toxicities induced by methotrexate in children with acute lymphoblastic leukemia
V Karpa, K Kalinderi, L Fidani, A Tragiannidis - Hematology Reports, 2023 - mdpi.com
Methotrexate (MTX), a structurally related substance to folic acid, is an important
chemotherapeutic agent used for decades in the treatment of pediatric acute lymphoblastic …
chemotherapeutic agent used for decades in the treatment of pediatric acute lymphoblastic …
MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy
M Umerez, A Gutierrez-Camino… - Pharmacogenomics …, 2017 - Taylor & Francis
Methotrexate (MTX) is an important component in the therapy used to treat childhood acute
lymphoblastic leukemia (ALL). Methylenetetrahydrofolate reductase (MTHFR) is a key …
lymphoblastic leukemia (ALL). Methylenetetrahydrofolate reductase (MTHFR) is a key …
Pharmacogenetics of anti-cancer drugs: state of the art and implementation–recommendations of the French National Network of Pharmacogenetics
S Quaranta, F Thomas - Therapies, 2017 - Elsevier
Individualized treatment is of special importance in oncology because the drugs used for
chemotherapy have a very narrow therapeutic index. Pharmacogenetics may contribute …
chemotherapy have a very narrow therapeutic index. Pharmacogenetics may contribute …
Implementation of pharmacogenetics to individualize treatment regimens for children with acute lymphoblastic leukemia
Despite major advances in the management and high cure rates of childhood acute
lymphoblastic leukemia (ALL), patients still suffer from many drug-induced toxicities …
lymphoblastic leukemia (ALL), patients still suffer from many drug-induced toxicities …
Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia
Á Gutierrez-Camino, M Umerez… - The …, 2018 - nature.com
Vincristine (VCR), an important component of childhood acute lymphoblastic leukemia (ALL)
therapy, can cause sensory and motor neurotoxicity. This neurotoxicity could lead to dose …
therapy, can cause sensory and motor neurotoxicity. This neurotoxicity could lead to dose …
Pharmacogenomics in pediatric oncology: mitigating adverse drug reactions while preserving efficacy
AA Elzagallaai, BC Carleton… - Annual review of …, 2021 - annualreviews.org
Cancer is the leading cause of death in American children older than 1 year of age. Major
developments in drugs such as thiopurines and optimization in clinical trial protocols for …
developments in drugs such as thiopurines and optimization in clinical trial protocols for …